Literature DB >> 36058948

The effect of a-Lipoic acid (ALA) on oxidative stress, inflammation, and apoptosis in high glucose-induced human corneal epithelial cells.

Zhen Li1,2, Yu Han2, Yan Ji3, Kexin Sun1,4, Yanyi Chen1,4, Ke Hu5,6.   

Abstract

PURPOSE: Oxidative stress and inflammation had been proved to play important role in the progression of diabetic keratopathy (DK). The excessive accumulation of AGEs and their bond to AGE receptor (RAGE) in corneas that cause the formation of oxygen radicals and the release of inflammatory cytokines, induce cell apoptosis. Our current study was aimed to evaluate the effect of ALA on AGEs accumulation as well as to study the molecular mechanism of ALA against AGE-RAGE axis mediated oxidative stress, apoptosis, and inflammation in HG-induced HCECs, so as to provide cytological basis for the treatment of DK.
METHODS: HCECs were cultured in a variety concentration of glucose medium (5.5, 10, 25, 30, 40, and 50 mM) for 48 h. The cell proliferation was evaluated by CCK-8 assay. Apoptosis was investigated with the Annexin V- fluorescein isothiocyanate (V-FITC)/PI kit, while, the apoptotic cells were determined by flow cytometer and TUNEL cells apoptosis Kit. According to the results of cell proliferation and cell apoptosis, 25 mM glucose medium was used in the following HG experiment. The effect of ALA on HG-induced HCECs was evaluated. The HCECs were treated with 5.5 mM glucose (normal glucose group, NG group), 5.5 mM glucose + 22.5 mM mannitol (osmotic pressure control group, OP group), 25 mM glucose (high glucose group, HG group) and 25 mM glucose + ALA (HG + ALA group) for 24 and 48 h. The accumulation of intracellular AGEs was detected by ELISA kit. The RAGE, catalase (CAT), superoxide dismutase 2 (SOD2), cleaved cysteine-aspartic acid protease-3 (Cleaved caspase-3), Toll-like receptors 4 (TLR4), Nod-like receptor protein 3 (NLRP3) inflammasome, interleukin 1 beta (IL-1 ß), and interleukin 18 (IL-18) were quantified by RT-PCR, Western blotting, and Immunofluorescence, respectively. Reactive oxygen species (ROS) production was evaluated by fluorescence microscope and fluorescence microplate reader.
RESULTS: When the glucose medium was higher than 25 mM, cell proliferation was significantly inhibited and apoptosis ratio was increased (P < 0.001). In HG environment, ALA treatment alleviated the inhibition of HCECs in a dose-dependent manner, 25 μM ALA was the minimum effective dose. ALA could significantly reduce the intracellular accumulation of AGEs (P < 0.001), activate protein and genes expression of CAT and SOD2 (P < 0.001), and therefore inhibited ROS-induced oxidative stress and cells apoptosis. Besides, ALA could effectively down-regulate the protein and gene level of RAGE, TLR4, NLRP3, IL-1B, IL-18 (P < 0.05), and therefore alleviated AGEs-RAGE-TLR4-NLRP3 pathway-induced inflammation in HG-induced HCECs.
CONCLUSION: Our study indicated that ALA could be a desired treatment for DK due to its potential capacity of reducing accumulation of advanced glycation end products (AGEs) and down-regulating AGE-RAGE axis-mediated oxidative stress, cell apoptosis, and inflammation in high glucose (HG)-induced human corneal epithelial cells (HCECs), which may provide cytological basis for therapeutic targets that are ultimately of clinical benefit.
© 2022. The Author(s).

Entities:  

Keywords:  Apoptosis; Diabetic keratopathy; Glucose; Glycation End Products; Human corneal epithelial cells; Proliferation

Year:  2022        PMID: 36058948     DOI: 10.1007/s00417-022-05784-6

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.535


  19 in total

1.  Increased expression of advanced glycation end-products and their receptor, and activation of nuclear factor kappa-B in lacrimal glands of diabetic rats.

Authors:  M Alves; V C Calegari; D A Cunha; M J A Saad; L A Velloso; E M Rocha
Journal:  Diabetologia       Date:  2005-11-08       Impact factor: 10.122

2.  Advanced glycation end products in diabetic corneas.

Authors:  Y Kaji; T Usui; T Oshika; M Matsubara; H Yamashita; M Araie; T Murata; T Ishibashi; R Nagai; S Horiuchi; S Amano
Journal:  Invest Ophthalmol Vis Sci       Date:  2000-02       Impact factor: 4.799

3.  RAGE silencing deters CML-AGE induced inflammation and TLR4 expression in endothelial cells.

Authors:  Ravi Ramya; Karunakaran Coral; Subramaniam Rajesh Bharathidevi
Journal:  Exp Eye Res       Date:  2021-02-25       Impact factor: 3.467

4.  Effect of advanced glycation end products on accelerated apoptosis of retinal capillary cells under in vitro conditions.

Authors:  Renu A Kowluru
Journal:  Life Sci       Date:  2005-01-14       Impact factor: 5.037

5.  A cross talk between class A scavenger receptor and receptor for advanced glycation end-products contributes to diabetic retinopathy.

Authors:  Ke Ma; Yiming Xu; Chenchen Wang; Nan Li; Kexue Li; Yan Zhang; Xiaoyu Li; Qing Yang; Hanwen Zhang; Xudong Zhu; Hui Bai; Jingjing Ben; Qingqing Ding; Keran Li; Qin Jiang; Yong Xu; Qi Chen
Journal:  Am J Physiol Endocrinol Metab       Date:  2014-10-28       Impact factor: 4.310

6.  Efficacy of alpha-lipoic acid against diabetic cataract in rat.

Authors:  Masami Kojima; Li Sun; Ikuho Hata; Yasuo Sakamoto; Hiroshi Sasaki; Kazuyuki Sasaki
Journal:  Jpn J Ophthalmol       Date:  2007-02-09       Impact factor: 2.447

Review 7.  Too sweet: Problems of protein glycation in the eye.

Authors:  Eloy Bejarano; Allen Taylor
Journal:  Exp Eye Res       Date:  2018-08-24       Impact factor: 3.467

8.  Potential of nonoral α-lipoic acid aqueous formulations to reduce ocular microvascular complications in a streptozotocin-induced diabetic rat model.

Authors:  Chen-Ling Chen; Wen-Sheng Cheng; Jiin-Long Chen; Chiao-Hsi Chiang
Journal:  J Ocul Pharmacol Ther       Date:  2013-07-13       Impact factor: 2.671

9.  Oxidized LDL, homocysteine, homocysteine thiolactone and advanced glycation end products act as pro-oxidant metabolites inducing cytokine release, macrophage infiltration and pro-angiogenic effect in ARPE-19 cells.

Authors:  Kannadasan AnandBabu; Parveen Sen; Narayanasamy Angayarkanni
Journal:  PLoS One       Date:  2019-05-14       Impact factor: 3.240

10.  (R)-α-Lipoic acid inhibits fructose-induced myoglobin fructation and the formation of advanced glycation end products (AGEs) in vitro.

Authors:  Hardik Ghelani; Valentina Razmovski-Naumovski; Rajeswara Rao Pragada; Srinivas Nammi
Journal:  BMC Complement Altern Med       Date:  2018-01-15       Impact factor: 3.659

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.